Blaszczyk-Thurin M - Search Results

1

A modified DNA vaccine to p53 induces protective immunity to challenge with a chemically induced sarcoma cell line.

Deng H, Kowalczyk D, O I, Blaszczyk-Thurin M, Quan Xiang Z, Giles-Davis W, Ertl HC. Deng H, et al. Among authors: blaszczyk thurin m. Cell Immunol. 2002 Jan;215(1):20-31. doi: 10.1016/s0008-8749(02)00004-7. Cell Immunol. 2002. PMID: 12142033

2

A dendritic cell vaccine induces protective immunity to intracranial growth of glioma.

Insug O, Ku G, Ertl HC, Blaszczyk-Thurin M. Insug O, et al. Among authors: blaszczyk thurin m. Anticancer Res. 2002 Mar-Apr;22(2A):613-21. Anticancer Res. 2002. PMID: 12014629

3

A DNA vaccine expressing tyrosinase-related protein-2 induces T-cell-mediated protection against mouse glioblastoma.

O I, Blaszczyk-Thurin M, Shen CT, Ertl HC. O I, et al. Among authors: blaszczyk thurin m. Cancer Gene Ther. 2003 Sep;10(9):678-88. doi: 10.1038/sj.cgt.7700620. Cancer Gene Ther. 2003. PMID: 12944987

4

An experimental vaccine expressing wild-type p53 induces protective immunity against glioblastoma cells with high levels of endogenous p53.

Blaszczyk-Thurin M, Ertl IO, Ertl HC. Blaszczyk-Thurin M, et al. Scand J Immunol. 2002 Oct;56(4):361-75. doi: 10.1046/j.1365-3083.2002.01119.x. Scand J Immunol. 2002. PMID: 12234257 Free article.

5

Cytokines and costimulatory molecules as genetic adjuvants.

Pasquini S, Xiang Z, Wang Y, He Z, Deng H, Blaszczyk-Thurin M, Ertl HC. Pasquini S, et al. Immunol Cell Biol. 1997 Aug;75(4):397-401. doi: 10.1038/icb.1997.62. Immunol Cell Biol. 1997. PMID: 9315484 Review.

6

A method that allows easy characterization of tumor-infiltrating lymphocytes.

Kowalczyk DW, Wlazlo AP, Blaszczyk-Thurin M, Xiang ZQ, Giles-Davis W, Ertl HC. Kowalczyk DW, et al. Among authors: blaszczyk thurin m. J Immunol Methods. 2001 Jul 1;253(1-2):163-75. doi: 10.1016/s0022-1759(01)00356-8. J Immunol Methods. 2001. PMID: 11384678

7

Genetic adjuvants.

Ertl HC, Pasquini S, He Z, Deng H, Showe L, Giles-Davis W, Wang Y, O I, Marston H, Blaszczyk-Thurin M, Xiang Z. Ertl HC, et al. Methods Mol Med. 2000;29:251-60. doi: 10.1385/1-59259-688-6:251. Methods Mol Med. 2000. PMID: 21374325

8

A monoclonal antibody to a multiphosphorylated, conformational epitope at the carboxy-terminus of p53.

Otvos L Jr, Hoffmann R, Xiang ZQ, O I, Deng H, Wysocka M, Pease AM, Rogers ME, Blaszczyk-Thurin M, Ertl HC. Otvos L Jr, et al. Biochim Biophys Acta. 1998 Sep 16;1404(3):457-74. doi: 10.1016/s0167-4889(98)00087-1. Biochim Biophys Acta. 1998. PMID: 9739174 Free article.

9

Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses.

Kieber-Emmons T, Luo P, Qiu J, Chang TY, O I, Blaszczyk-Thurin M, Steplewski Z. Kieber-Emmons T, et al. Nat Biotechnol. 1999 Jul;17(7):660-5. doi: 10.1038/10870. Nat Biotechnol. 1999. PMID: 10404158

10

Role of SA-Le(a) and E-selectin in metastasis assessed with peptide antagonist.

O I, Otvos L, Kieber-Emmons T, Blaszczyk-Thurin M. O I, et al. Among authors: blaszczyk thurin m. Peptides. 2002 May;23(5):999-1010. doi: 10.1016/s0196-9781(02)00024-4. Peptides. 2002. PMID: 12084533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters